The qualitative nature of the primary immune response to HIV infection is a prognosticator of disease progression independent of the initial level of plasma viremia
about
sameAs
Viral immune evasion due to persistence of activated T cells without effector functionAnalysis of successful immune responses in persons infected with hepatitis C virusThe thalidomide analogue CC-3052 inhibits HIV-1 and tumour necrosis factor-alpha (TNF-alpha) expression in acutely and chronically infected cells in vitroTrue story about HIV: theory of viral sequestration and reserve infectionBeyond 51Cr release: New methods for assessing HIV-1-specific CD8+ T cell responses in peripheral blood and mucosal tissues.The role of cytokines which signal through the common gamma chain cytokine receptor in the reversal of HIV specific CD4(+) and CD8(+) T cell anergyBroad, intense anti-human immunodeficiency virus (HIV) ex vivo CD8(+) responses in HIV type 1-infected patients: comparison with anti-Epstein-Barr virus responses and changes during antiretroviral therapy.Immunologic pressure within class I-restricted cognate human immunodeficiency virus epitopes during highly active antiretroviral therapySimian immunodeficiency virus disease course is predicted by the extent of virus replication during primary infection.Analysis of the adult thymus in reconstitution of T lymphocytes in HIV-1 infectionEmergence and kinetics of simian immunodeficiency virus-specific CD8(+) T cells in the intestines of macaques during primary infection.Impairment of Gag-specific CD8(+) T-cell function in mucosal and systemic compartments of simian immunodeficiency virus mac251- and simian-human immunodeficiency virus KU2-infected macaques.Weak anti-HIV CD8(+) T-cell effector activity in HIV primary infectionLow proportions of CD28- CD8+ T cells expressing CD57 can be reversed by early ART initiation and predict mortality in treated HIV infection.Human immunodeficiency virus type I-specific CD8+ T cell subset abnormalities in chronic infection persist through effective antiretroviral therapySelection of virus variants and emergence of virus escape mutants after immunization with an epitope vaccine.Cellular immune responses to HIV.The immunology of Epstein-Barr virus infectionOptimization of a self antigen for presentation of multiple epitopes in cancer immunityUse of RT-defective HIV virions: new tool to evaluate specific response in chronic asymptomatic HIV-infected individualsTreatment of primary HIV-1 infection with cyclosporin A coupled with highly active antiretroviral therapy.The functional CD8 T cell response to HIV becomes type-specific in progressive disease.Human CD8+ T cells from TB pleurisy respond to four immunodominant epitopes in Mtb CFP10 restricted by HLA-B alleles.Early highly active antiretroviral therapy for acute HIV-1 infection preserves immune function of CD8+ and CD4+ T lymphocytesEffect of MHC haplotype on immune response upon experimental SHIVSF162P4cy infection of Mauritian cynomolgus macaquesProtein kinase Ctheta is a specific target for inhibition of the HIV type 1 replication in CD4+ T lymphocytes.HIV-specific regulatory T cells are associated with higher CD4 cell counts in primary infectionProgress in the development of an HIV vaccine.Quantitative analysis of T cell receptor diversity in clinical samples of human peripheral blood.Progress towards the use of Listeria monocytogenes as a live bacterial vaccine vector for the delivery of HIV antigens.Innate immune control of HIV.Substantial differences in specificity of HIV-specific cytotoxic T cells in acute and chronic HIV infectionDeterminants of human immunodeficiency virus type 1 escape from the primary CD8+ cytotoxic T lymphocyte response.Functionally inert HIV-specific cytotoxic T lymphocytes do not play a major role in chronically infected adults and childrenEmergence of polyfunctional CD8+ T cells after prolonged suppression of human immunodeficiency virus replication by antiretroviral therapyThe extent of early viral replication is a critical determinant of the natural history of simian immunodeficiency virus infectionEvidence for rapid disappearance of initially expanded HIV-specific CD8+ T cell clones during primary HIV infectionAntigen-specific T-cell-mediated immunity after HIV-1 infection: implications for vaccine control of HIV development.Immune activation and IL-12 production during acute/early HIV infection in the absence and presence of highly active, antiretroviral therapy.Immunophenotypic alterations in acute and early HIV infection
P2860
Q24646943-376C9EDD-E324-4E00-B7A0-13482F6E6BA6Q27860698-8F4B3373-57F8-4FFC-8831-9A56548A2402Q28343837-196B6159-019A-4E76-AB8C-B18A4B380472Q28732833-930A4E38-9097-4ACE-B6DC-693C569C63FEQ30332080-12063745-53E3-4FBD-9180-EA8FC4AF47E4Q33279519-2FE10EC5-4EF6-4191-9D8B-ADA9B5867E18Q33648533-9ED8133C-E783-481F-A5B4-E90E498AAE39Q33737646-6A9DCB83-16B2-4D5B-9AA1-70D799AA3253Q33813926-49C114AD-B7D5-4BBA-B76D-E5134C78F44AQ33842754-BD5497C5-2F5A-4BF7-A04B-235BA6E49E8AQ33848383-59CD1ED8-1A95-4339-88B0-6A928456B5C5Q33849823-142AB67F-66E0-40CA-9E38-E3EC917A6028Q33880339-2481FFD9-2BD1-4C3C-BCD5-A3867CB859CEQ33947817-C09FC6C7-0AF4-44E1-B1BD-26A43D64B721Q33952015-37B9C71F-B730-49F2-B1DB-17F660524417Q34069815-D53C69E7-E5B1-4006-A909-8C2BF08F6EFDQ34223069-5CD78B06-6A45-4664-9F0E-592AB10BDB9BQ34225567-DC2DED20-B682-4215-B689-4F09AC4BD99FQ34537491-C4BB0DFB-8921-4A09-8984-E5EA662438F2Q34630184-67DED8CE-40CF-489B-997A-3B1DD966E7BEQ34789249-16239364-2045-4ED3-9C0D-EB5B56911C5EQ34815358-86E28A37-84ED-43A5-A2A5-67556219C020Q35070059-5B2588D9-0A9F-4E0C-BEFD-082211809987Q35110576-72121420-B502-4EAC-8396-1B65833AAB21Q35138516-284C52FB-1380-4824-9C08-CCE53C02FA30Q35144874-63B1DFAB-A38A-4442-8795-3746D5538777Q35372836-EA480ED4-777D-4721-B3BE-BEA2113CD681Q35581128-CB21DB1A-8D95-4E0A-9B2F-9BE05565C1A7Q35661328-A67D2D2B-9C0D-4D89-BB73-7DE9FF5FC158Q35851806-951CE071-7A7B-40DD-80E4-8B2C274150E0Q36065864-0F131134-E19D-45A1-BF60-CA0688EFC8EAQ36369054-DC4D2EB5-F409-492F-8A3A-1A65D857DE78Q36399559-6598DE61-C285-4E59-858B-18EAE4CEC704Q36404594-6563C8F4-2FC7-4E79-AE1D-25B047B669A0Q36498230-DB50F284-7CA7-40EF-8A9C-23BE42B0893DQ36548993-E06F4BDE-715C-4426-83E4-9319D1CE1E03Q36576849-AA2E30E0-D5D6-4251-8D0C-7B4CAE69A531Q36600351-C38E320C-B26C-4D0E-AC4B-A59C5CDD63F5Q37039032-458D35FC-0103-47EE-930F-6041C0F1CC61Q37243692-88EB7AE8-6A7D-4C67-99EA-42BF83A5C03C
P2860
The qualitative nature of the primary immune response to HIV infection is a prognosticator of disease progression independent of the initial level of plasma viremia
description
1997 nî lūn-bûn
@nan
1997 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1997 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
name
The qualitative nature of the ...... nitial level of plasma viremia
@ast
The qualitative nature of the ...... nitial level of plasma viremia
@en
The qualitative nature of the ...... nitial level of plasma viremia
@nl
type
label
The qualitative nature of the ...... nitial level of plasma viremia
@ast
The qualitative nature of the ...... nitial level of plasma viremia
@en
The qualitative nature of the ...... nitial level of plasma viremia
@nl
prefLabel
The qualitative nature of the ...... nitial level of plasma viremia
@ast
The qualitative nature of the ...... nitial level of plasma viremia
@en
The qualitative nature of the ...... nitial level of plasma viremia
@nl
P2093
P2860
P356
P1476
The qualitative nature of the ...... nitial level of plasma viremia
@en
P2093
A. Lazzarin
C. Graziosi
G. M. Shaw
G. Pantaleo
G. Tambussi
H. Soudeyns
J. F. Demarest
M. Daucher
P2860
P304
P356
10.1073/PNAS.94.1.254
P407
P577
1997-01-07T00:00:00Z